• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Techcouver.com

 
  • News
  • Events
  • Interviews
  • Thought Leadership
  • Web Summit Vancouver
  • Jobs
  • About
    • Contact Us

Chinook Therapeutics Merges With Nasdaq-Traded Aduro Biotech

June 3, 2020 by Techcouver Newsdesk

Vancouver’s Chinook Therapeutics announced today that they are merging with Nasdaq-traded Aduro Biotech.

Chinook is a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization of precision medicines for kidney diseases.

Last year Chinook raised a $65 million Series A round led by founding investor Versant Ventures.

Under the merger agreement, Seattle-based Aduro will acquire all of the outstanding capital stock of Chinook in exchange for shares of Aduro common stock representing approximately 50 percent of Aduro’s outstanding common stock.

The combined company is expected to have approximately $200 million in cash, cash equivalents and marketable securities at closing, including $25 million in additional financing committed by Chinook’s existing investors.

Following closing, which is expected to occur in the second half of 2020, Aduro will be renamed Chinook Therapeutics and is expected to trade on the Nasdaq under the ticker symbol “KDNY”.

“After an extensive and thorough review of strategic and potentially transformative options for Aduro, we are very pleased to announce a proposed merger with Chinook,” said Stephen T. Isaacs, chairman, president and chief executive officer of Aduro.

“We believe the combined company’s strong pipeline, near-term milestones, seasoned leadership team and focus on kidney diseases offer an excellent opportunity to benefit patients and provide value to our stockholders.”

Filed Under: News Tagged With: Chinook Therapeutics

 

Primary Sidebar

 

Stay Connected

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter

Community Partners

About Us

Techcouver provides real-time reporting and analysis of emerging technology news in Vancouver and throughout British … READ MORE... about About Us

Copyright © 2025 Incubate Ventures | Techtalent.ca · Decoder.ca · Calgary.tech · Fintech.ca · CleanEnergy.ca | Privacy